Live from the NIH registry
Studies recruiting near Riverside right now
Top 25 of 946 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (28.3 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Loma Linda, California (10.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Nurix Therapeutics, Inc.
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Upland — Upland, California (18.2 mi)
· Sponsor: City of Hope Medical Center
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
North America Research Institute — San Dimas, California (26.3 mi)
· Sponsor: R1 Therapeutics
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Riverside Community Hospital — Riverside, California (1.1 mi)
· Sponsor: Duke University
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Tustin, California (28.1 mi)
· Sponsor: Ambros Therapeutics, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — Laguna Hills, California (29.0 mi)
· Sponsor: Salma Health, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Riverside — Riverside, California (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Loma Linda University — Loma Linda, California (10.8 mi)
· Sponsor: VisionCare, Inc.
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Upland, California (18.2 mi)
· Sponsor: GlaxoSmithKline
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of California, Irvine — Orange, California (28.3 mi)
· Sponsor: Kura Oncology, Inc.
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer, Neoplasms
N/A
Interventional 35 participants sought
UCI Health - Yorba Linda — Yorba Linda, California (24.2 mi)
· Sponsor: University of California, Irvine
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (28.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Gen 2 Battrode Wear Study
Adhesive Wear Time
N/A
Interventional 30 participants sought
Orange County Research Center — Lake Forest, California (26.3 mi)
· Sponsor: Baxter Healthcare Corporation
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0076) — Orange, California (28.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Orange, California (28.3 mi)
· Sponsor: AstraZeneca
Evaluating the Impact of Training for IHSS Workers
Home Care for Elderly or Disabled Individuals
N/A
Interventional 2,500 participants sought
San Bernardino County — San Bernardino, California (13.2 mi)
· Sponsor: Abdul Latif Jameel Poverty Action Lab
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Riverside — Riverside, California (1.1 mi)
· Sponsor: NRG Oncology
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Infinity Clinical Research — Norco, California (8.8 mi)
· Sponsor: Crystalys Therapeutics
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Orange, California (28.3 mi)
· Sponsor: Daiichi Sankyo